mRNA expression levels of IL4, IL5, and IL13 are increased in sputum cells from asthmatic patients in comparison to controls and can be used as molecular biomarkers to categorize patients into T2-high and T2-low asthma endotypes similarly as described previously [5,11]. This evidence concerns the gene IL5 and asthma.